gp91phox-Containing NADPH Oxidase Mediates Endothelial Dysfunction in Renovascular Hypertension

Circulation

Volumn 109, Issue 14, 2004, Pages 1795-1801

  Jung, O ^a   Schreiber, J G ^a   Geiger, H ^a   Pedrazzini, T ^b   Busse, R ^a   Brandes, Ralf P ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b University of Lausanne Medical Center   (Switzerland)

Author keywords

Angiotensin; Endothelium; Hypertension; Stress, oxidative

Indexed keywords

ACETYLCHOLINE; GLYCOPROTEIN GP 91; NITRIC OXIDE; PROTEIN KINASE C; RAC PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TIRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; ORGAN CULTURE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENOVASCULAR HYPERTENSION; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; AORTA; BACTERIAL TOXINS; CARDIOMYOPATHY, HYPERTROPHIC; CYTOCHROMES B; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GLYCOPROTEINS; HYPERTENSION, RENOVASCULAR; INDOLES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; NITRIC OXIDE; ORGAN CULTURE TECHNIQUES; POLYETHYLENE GLYCOLS; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SUPEROXIDE DISMUTASE; SUPEROXIDES; TIRON; TYRPHOSTINS; VASODILATION; VASODILATOR AGENTS;

EID: 3342983728     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000124223.00113.A4     Document Type: Article

References (26)

1. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899-1906.
2. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840-844.
3. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494-501.
4. Gorlach A, Brandes RP, Nguyen K, et al. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res. 2000;87:26-32.
5. Laursen JB, Rajagopalan S, Galis Z, et al. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation. 1997;95:588-593.
6. Rajagopalan S, Kurz S, Münzel T, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest. 1996;97:1916-1923.
7. Rey FE, Li XC, Carretero OA, et al. Perivascular superoxide anion contributes to impairment of endothelium-dependent relaxation: role of gp91(phox). Circulation. 2002;106:2497-2502.
8. Sorescu D, Weiss D, Lassegue B, et al. Superoxide production and expression of NOx family proteins in human atherosclerosis. Circulation. 2002;105:1429-1435.
9. Lassegue B, Sorescu D, Szocs K, et al. Novel gp91(phox) homologues in vascular smooth muscle cells: NOx1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res. 2001;88:888-894.
10. Sohn HY, Raff U, Hoffmann A, et al. Differential role of angiotensin II receptor subtypes on endothelial superoxide formation. Br J Pharmacol. 2000;131:667-672.
11. Higashi Y, Sasaki S, Nakagawa K, et al. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med. 2002;346:1954-1962.
12. Wiesel P, Mazzolai L, Nussberger J, et al. Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension. 1997;29:1025-1030.
13. 2- and systolic blood pressure in mice. Circ Res. 2001;89:408-414.
14. Seshiah PN, Weber DS, Rocic P, et al. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res. 2002;91:406-413.
15. Mohazzab H, Kaminski PM, Agarwal R, et al. Potential role of a membrane-bound NADH oxidoreductase in nitric oxide release and arterial relaxation to nitroprusside. Circ Res. 1999;84:220-228.
16. Rueckschloss U, Quinn MT, Holtz J, et al. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2002;22:1845-1851.
17. Griendling KK, Minieri CA, Ollerenshaw JD, et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
18. Cosentino F, Katusic ZS. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation. 1995;91:139-144.
19. Laursen JB, Somers M, Kurz S, et al. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation. 2001;103:1282-1288.
20. Landmesser U, Dikalov S, Price SR, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003;111:1201-1209.
21. Heitzer T, Wenzel U, Hink U, et al. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int. 1999;55:252-260.
22. Bayer AL, Heidkamp MC, Patel N, et al. Alterations in protein kinase C isoenzyme expression and autophosphorylation during the progression of pressure overload-induced left ventricular hypertrophy. Mol Cell Biochem. 2003;242:145-152.
23. Soloviev AI, Parshikov AV, Stefanov AV. Evidence for the involvement of protein kinase C in depression of endothelium-dependent vascular responses in spontaneously hypertensive rats. J Vasc Res. 1998;35:325-331.
24. Ruan X, Arendshorst WJ. Role of protein kinase C in angiotensin II-induced renal vasoconstriction in genetically hypertensive rats. Am J Physiol. 1996;270:F945-F952.
25. Kanayama Y, Negoro N, Okamura M, et al. Modulation of protein kinase C in aorta of spontaneously hypertensive rats with enalapril treatment. Osaka City Med J. 1994;40:83-97.
26. Jung O, Marklund SL, Geiger H, et al. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ Res. 2003;93:622-629.